Predictors of Response to Adjunctive Osmotic-Release Methylphenidate or Placebo in Patients With Major Depressive Disorder

Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder

(2013) Ashwin A. Patkar et al.   CNS DRUGS

Modafinil Augmentation Therapy in Unipolar and Bipolar Depression

(2013) Alexander J. Goss et al.   JOURNAL OF CLINICAL PSYCHIATRY

Reliability of the Hamilton Rating Scale for Depression: A meta-analysis over a period of 49years

(2011) Goran Trajković et al.   PSYCHIATRY RESEARCH

National Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry

(2010) Ramin Mojtabai et al.   ARCHIVES OF GENERAL PSYCHIATRY

Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression

(2010) Michael E. Thase et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.

(2009) Raymond W. Lam et al.   JOURNAL OF AFFECTIVE DISORDERS

Osmotic-Release Oral System Methylphenidate Augmentation of Antidepressant Monotherapy in Major Depressive Disorder

(2009) Arun V. Ravindran et al.   JOURNAL OF CLINICAL PSYCHIATRY

Managing Weight Gain and Metabolic Issues in Patients Treated With Atypical Antipsychotics

(2009) David C. Henderson   JOURNAL OF CLINICAL PSYCHIATRY

Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder

(2009) Armin Szegedi et al.   JOURNAL OF CLINICAL PSYCHIATRY

A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

(2008) GI Papakostas et al.   JOURNAL OF PSYCHOPHARMACOLOGY